Navigation Links
Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
Date:9/14/2007

PITTSBURGH, Sept. 14 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE: MYL) today announced the appointment of M. Fabiana Lacerca to the position of Senior Vice President and Chief Compliance Officer.

Ms. Lacerca joins Mylan from Bristol-Meyers Squibb where she was Director of Compliance for Latin America, Canada and Puerto Rico. While there, she was responsible for all compliance-related matters in those regions. Prior to Bristol-Meyers Squibb, Ms. Lacerca held executive and senior counsel positions with Merck & Co., Microsoft and AT&T.

Ms. Lacerca has extensive experience in the areas of multi-jurisdictional corporate compliance, international business transactions, pharmaceutical industry regulation, corporate policy and international environmental law and has advised on opportunities and legal trends within the government as well as corporate sectors.

Mylan Vice Chairman and CEO Robert J. Coury commented: "As we transition to becoming a global leader in our industry we are committed to maintaining a culture of integrity and quality across all lines of our business. It is with great pleasure, therefore, to welcome Fabiana to Mylan. Fabiana has tremendous experience and an exemplary track record in international corporate compliance, which she has gained advising a number of Fortune 100 companies on a wide range of issues, including corporate policy and cross border transactions. Fabiana's extensive experience counseling companies in the pharmaceutical industry with operations in multiple countries will be invaluable to Mylan's operations around the world."

Ms. Lacerca earned a master's of law (LL.M) from UCLA; a specialization in international environmental law from the Universidad de Buenos Aires; and a bachelor's of law from the Universidad de Buenos Aires.

Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc., and a controlling interest in Matrix Laboratories Limited, India. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products. For more information about Mylan, please visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Laboratories Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ... February 20, 2017 , ... ... to purchase a new ultrasound-enhanced thrombolysis machine, a state-of-the-art device that breaks up ... facilitated by the Pepin Family Foundation. , “We greatly appreciate this gift from ...
(Date:2/19/2017)... ... February 19, 2017 , ... Orbita, ... will join forces with Healthwise ® at HIMSS 2017 to ... leader in evidence-based health education, technology and services, will demonstrate a voice-powered knowedge ...
(Date:2/18/2017)... ... 17, 2017 , ... Park Cities Pet Sitter President, Joette White, has been ... Radio network. The episode, which was posted this week, features a 30-minute interview ... to Park Cities Pet Sitter’s being awarded the 2017 National Association of Professional Pet ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Alliance Healthcare Foundation (AHF) ... further positively impact the health and wellness of our community in San Diego ... duty to seriously consider releasing our assets beyond our 5% targeted distribution each ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 ... manufacturers distinguish between corrective action (CA) and preventive action (PA)? , The methods ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... Research and Markets has announced the addition of the ... Product (RFID refrigerators and RFID freezers), Application (Diagnostic centers, Blood banks ... ... RFID Blood Refrigerator and Freezer Market is poised to grow at ... This industry report analyzes the global markets for RFID Blood ...
(Date:2/20/2017)... According to a new market research report "Pulmonary/ Respiratory Drug ... dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications ... to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in ... Continue Reading ... ...
(Date:2/20/2017)... 20, 2017 Adequate intake of ... phosphorous minerals in one,s body. Consumers are well aware ... maintaining a healthy composition of bones and teeth. Consumption ... is growing in the world. Medical research and clinical ... ingredients for treatment of prevalent disorders such as multiple ...
Breaking Medicine Technology: